Strategic Acquisition Paragon Healthcare has recently been involved in major ownership changes, with Anthem acquiring Paragon and Elevance Health previously acquiring the company. This indicates potential integration opportunities with payer-led care models and newly aligned distribution channels that could open cross-selling of infusion services and specialty pharmacy collaborations.

Payer Alignment The recent acquisitions by Anthem/CarelonRx and Elevance Health suggest a strong payer-focused trajectory. This creates sales opportunities to position Paragon’s infusion and specialty pharmacy capabilities as integrated solutions within payer networks, care coordination initiatives, and value-based care programs.

Nationwide Footprint With nearly 50 infusion centers, 15+ home infusion pharmacies, and licensing across all 50 states, Paragon offers a broad, scalable platform for expanding infusion services, home infusion care, and niche therapies—presenting opportunities to partner with health systems seeking wide geographic coverage.

High Clinical Activity 20K+ patients served monthly and 16.5K annual nursing visits reflect a high-touch, high-visit model. This indicates potential for upsell of additional infusible and injectable therapies, home infusion support, and related clinical services to existing patient cohorts and partner networks.

Rare and Orphan Focus Past expansion into Rare and Orphan disease spaces via ParagonRare signals a niche growth area. Sales opportunities exist to align specialty therapies, clinical trials support, and customized infusion pathways with rare disease programs, biopharma collaborations, and academic centers.